← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2011Last known activity
Sep 1, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT02219776Lead sponsorPhase 3Sep 1, 2015
- NCT01460667Study directorN/AOct 1, 2011
- NCT01460667Lead sponsorN/AOct 1, 2011
- NCT01460667Reponsible party - principal investigatorN/AOct 1, 2011
Details
- Last known activity
- Sep 1, 2015